GILT required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis

Metabolic Brain Disease

Volumn 27, Issue 2, 2012, Pages 143-149

  Burrows, Gregory G ^a,b   Meza Romero, Roberto ^a,b,c   Huan, Jianya ^a,b   Sinha, Sushmita ^a,c   Mooney, Jeffrey L ^a,b   Vandenbark, Arthur A ^a,b,c   Offner, Halina ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

EAE; GILT mice; MHC class II; RTL550 CYS Mog

Indexed keywords

CYSTEINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; MAJOR HISTOCOMPATIBILITY ANTIGEN; RECOMBINANT T LYMPHOCYTE RECEPTOR LIGAND 550 CYSTEINE MOG PEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; ENDOSOME; IMMUNIZATION; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN;

AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOSOMES; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PEPTIDE FRAGMENTS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

MUS;

EID: 84863459730     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9289-7     Document Type: Article

References (27)

1. Adamus G, Burrows GG, Vandenbark AA, Offner H (2006) Treatment of autoimmune anterior uveitis with recombinant TCR ligands. Invest Ophthalmol Vis Sci 47(6):2555-2561. doi:10.1167/iovs.05-1242
2. Arthur A. Vandenbark RM-R, Shayne Andrew, Gil, Benedek JH, Yuan K. Chou, Abigail C. Buenafe, Rony Dahan, Yoram, Reiter JM, Halina Offner and Gregory G. Burrows (2012) Binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance. Nature Immunology Submitted Bogunovic B
3. Srinivasan P, Ueda Y, Tomita Y, Maric M (2010) Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire. PLoS One 5(5): e10599. doi:10.1371/journal.pone.0010599
4. Burrows GG, Bebo BF Jr, Adlard KL, Vandenbark AA, Offner H (1998) Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis. J Immunol 161(11):5987-5996
5. Burrows GG, Chang JW, Bachinger HP, Bourdette DN, Offner H, Vandenbark AA (1999) Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng 12(9):771-778
6. Burrows GG, Adlard KL, Bebo BF Jr, Chang JW, Tenditnyy K, Vandenbark AA, Offner H (2000) Regulation of encephalitogenic T cells with recombinant TCR ligands. J Immunol 164(12):6366-6371
7. Burrows GG, Chou YK, Wang C, Chang JW, Finn TP, Culbertson NE, Kim J, Bourdette DN, Lewinsohn DA, Lewinsohn DM, Ikeda M, Yoshioka T, Allen CN, Offner H, Vandenbark AA (2001) Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol 167(8):4386-4395
8. Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D (2006) Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient! Arthritis Rheum 54(11):3381-3389. doi:10.1002/art.22206
9. Chang JW, Mechling DE, Bachinger HP, Burrows GG (2001) Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2. J Biol Chem 276(26):24170-24176. doi:10.1074/jbc. M101808200
10. Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G (2005) IgG subclass distribution of the rheumatoid arthritisspecific autoantibodies to citrullinated fibrin. Clin Exp Immunol 139(3):542-550. doi:10.1111/j.1365-2249.2004.02708.x
11. Dahan R, Tabul M, Chou YK, Meza-Romero R, Andrew S, Ferro AJ, Burrows GG, Offner H, Vandenbark AA, Reiter Y (2011) TCRlike antibodies distinguish conformational and functional differences in two-versus four-domain auto reactive MHC class IIpeptide complexes. Eur J Immunol 41(5):1465-1479. doi:10.1002/eji.201041241
12. Fontenot AP, Keizer TS, McCleskey M, Mack DG, Meza-Romero R, Huan J, Edwards DM, Chou YK, Vandenbark AA, Scott B, Burrows GG (2006) Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells. J Immunol 177(6):3874-3883
13. Huan JY, Meza-Romero R, Mooney JL, Chou YK, Vandenbark AA, Bachinger H-P, Burrows GG (2005) Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity. J Chem Tech & Biotech 80:2-12
14. Huan J, Kaler LJ, Mooney JL, Subramanian S, Hopke C, Vandenbark AA, Rosloniec EF, Burrows GG, Offner H (2008) MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis. J Immunol 180(2):1249-1257
15. Itakura A, Aslan JE, Sinha S, White-Adams TC, Patel IA, Meza-Romero R, Vandenbark AA, Burrows GG, Offner H, McCarty OJ (2010) Characterization of human platelet binding of recombinant T cell receptor ligand. J Neuroinflammation 7:75. doi:10.1186/1742-2094-7-75
16. Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L, Catrina AI (2006) Citrullination is an inflammation-dependent process. Ann Rheum Dis 65(9):1219-1222. doi:10.1136/ard.2005.049403
17. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, Alfonso C, Karlsson L, Flavell RA, Cresswell P (2001) Defective antigen processing in GILT-free mice. Science 294(5545):1361-1365. doi:10.1126/science.1065500294/ 5545/1361
18. McMahan RH, Watson L, Meza-Romero R, Burrows GG, Bourdette DN, Buenafe AC (2003) Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptide. J Biol Chem 278(33):30961-30970
19. Moscarello MA, Mastronardi FG, Wood DD (2007) The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 32(2):251-256. doi:10.1007/s11064-006-9144-5
20. Norton DL, Haque A (2009) Insights into the role of GILT in HLA class II antigen processing and presentation by Melanoma. J Oncol 2009:142959. doi:10.1155/2009/142959
21. Offner H, Sinha S, Burrows GG, Ferro AJ, Vandenbark AA (2011) RTL therapy for multiple sclerosis: a Phase I clinical study. J Neuroimmunol 231(1-2):7-14. doi:10.1016/j.jneuroim.2010.09.013
22. Quirke AM, Fisher BA, Kinloch AJ, Venables PJ (2011) Citrullination of autoantigens: upstream of TNFalpha in the pathogenesis of rheumatoid arthritis. FEBS Lett 585(23):3681-3688. doi:10.1016/j.febslet.2011.06.006
23. Sealy R, Chaka W, Surman S, Brown SA, Cresswell P, Hurwitz JL (2008) Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific Thelper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin Vaccine Immunol 15(4):713-719. doi:10.1128/CVI.00412-07
24. Sinha S, Miller L, Subramanian S, McCarty OJ, Proctor T, Meza-Romero R, Huan J, Burrows GG, Vandenbark AA, Offner H (2010) Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis. J Neuroimmunol 225(1-2):52-61. doi:10.1016/j.jneuroim.2010. 04.013
25. Vijayshree Yadav D N B, James Bowen, Sharon G. Lynch, David Mattson, Jana Preiningerova, Christopher Bever, Jack H. Simon, Andrew Goldstein, G. Burrows, Halina Offner, Al Ferro and Arthur Vandenbark (2012) Recombinant T-Cell Receptor Ligand (RTL) for treatment of multiple sclerosis: a double-blind, placebo-controlled, phase 1, dose-escalation study. Autoimmune Diseases In Press
26. Vossenaar ER, Zendman AJ, Van Venrooij WJ (2004) Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis. Arthritis Res Ther 6(1):1-5. doi:10.1186/ar1027 ar1027
27. Wang C, Mooney JL, Meza-Romero R, Chou YK, Huan J, Vandenbark AA, Offner H, Burrows GG (2003) Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation. J Immunol 171(4):1934-1940